Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) COO John Gallagher sold 431 shares of the stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $25.08, for a total value of $10,809.48. Following the completion of the transaction, the chief operating officer owned 32,203 shares in the company, valued at approximately $807,651.24. This represents a 1.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trupanion Stock Down 5.3%
TRUP stock traded down $1.37 during midday trading on Thursday, reaching $24.48. 294,301 shares of the company’s stock traded hands, compared to its average volume of 415,608. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $57.00. The company has a market cap of $1.07 billion, a price-to-earnings ratio of 41.49 and a beta of 1.39. The firm’s fifty day moving average price is $24.22 and its 200-day moving average price is $26.57. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping the consensus estimate of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The company had revenue of $384.05 million during the quarter, compared to the consensus estimate of $379.77 million. During the same period in the previous year, the firm posted ($0.03) earnings per share. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. As a group, sell-side analysts forecast that Trupanion, Inc. will post 0.55 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
View Our Latest Report on Trupanion
Hedge Funds Weigh In On Trupanion
Several hedge funds have recently modified their holdings of TRUP. Millennium Management LLC boosted its stake in shares of Trupanion by 185.8% in the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock worth $26,790,000 after buying an additional 402,421 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Trupanion by 116.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock worth $17,826,000 after acquiring an additional 256,559 shares during the period. Two Sigma Investments LP lifted its holdings in Trupanion by 3,201.0% during the third quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock worth $9,713,000 after acquiring an additional 217,634 shares during the period. Polar Capital Holdings Plc boosted its position in Trupanion by 13.5% in the fourth quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock worth $55,121,000 after purchasing an additional 175,000 shares during the last quarter. Finally, Marshall Wace LLP boosted its position in Trupanion by 15.5% in the third quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock worth $52,462,000 after purchasing an additional 163,101 shares during the last quarter.
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Further Reading
- Five stocks we like better than Trupanion
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
